EUVIMEDEUVIMED entdecken
Crossref

Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time–Temperature Transformation

Rahul Lalge iD, N S Krishna Kumar, Raj Suryanarayanan iD

Molecular Pharmaceutics · 07.08.2023 · 20 (8) · 4196-4209

DOI: 10.1021/acs.molpharmaceut.3c00313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 26.06.2023. Verfasst von Rahul Lalge und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-177 WDH, 308 Harvard Street S.E., Minneapolis, Minnesota 55455, United S…. Hauptthemen laut MEDLINE: Povidone, Polymers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: William and Mildred Peters endowment fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In an earlier investigation, the critical cooling rate to prevent drug crystallization (CRcrit) during the preparation of nifedipine (NIF) amorphous solid dispersions (ASDs) was determined through a time-temperature transformation (TTT) diagram (Lalge et al. Mol. Pharmaceutics 2023, 20 (3), 1806-1817). The current study aims to use the TTT diagram to determine the critical cooling rate to prevent drug nucleation (CRcrit N) during the preparation of ASDs. ASDs were prepared with each polyvinylpyrrolidone (PVP) and hydroxypropyl methylcellulose acetate succinate (HPMCAS). The dispersions were first stored under conditions promoting nucleation and then heated to the temperature that favors crystallization. The crystallization onset time (tC) was determined by differential scanning calorimetry and synchrotron X-ray diffractometry. TTT diagrams for nucleation were generated, which provided the critical nucleation temperature (50 °C) and the critical cooling rate to avoid nucleation (CRcrit N). The strength of the drug-polymer interactions as well as the polymer concentration affected the CRcrit N, with PVP having a stronger interaction than HPMCAS. The CRcrit of amorphous NIF was ∼17.5 °C/min. The addition of a 20% w/w polymer resulted in CRcrit of ∼0.05 and 0.2 °C/min and CRcrit N of ∼4.1 and 8.1 °C/min for the dispersions prepared with PVP and HPMCAS, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PovidonePolymersTemperatureCrystallizationPhase TransitionSolubilityMethylcelluloseDrug Stability

Stichwörter der Autor:innen

amorphous solid dispersioncrystallizationdrug−polymer interactionshot-melt extrusionhydroxypropyl methylcellulose acetate succinate (HPMCAS)nifedipinenucleationpolyvinylpyrrolidone (PVP)time−temperature transformation

Substanzen

PovidonePolymersMethylcellulose

Autor:innen und Institutionen

  • Department of Pharmaceutics, College of Pharmacy, University of Minnesota, 9-177 WDH, 308 Harvard Street S.E., Minneapolis, Minnesota 55455, United States.

ORCID-Profile: Rahul Lalge, Raj Suryanarayanan

Förderung

  • William and Mildred Peters endowment fund

Zitieren

APA

Lalge, R., Kumar, N. S. K., & Suryanarayanan, R. (2023). Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time–Temperature Transformation. Molecular Pharmaceutics, 20(8), 4196-4209. https://doi.org/10.1021/acs.molpharmaceut.3c00313

Vancouver

Lalge R, Kumar NSK, Suryanarayanan R. Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time–Temperature Transformation. Molecular Pharmaceutics. 2023;20(8):4196-4209. doi:10.1021/acs.molpharmaceut.3c00313

BibTeX
@article{Lalge2023,
  author = {Lalge, Rahul and Kumar, N S Krishna and Suryanarayanan, Raj},
  title = {Understanding the Effect of Nucleation in Amorphous Solid Dispersions through Time–Temperature Transformation},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {8},
  pages = {4196--4209},
  doi = {10.1021/acs.molpharmaceut.3c00313}
}
Kostenlos starten →